Medpolmatsp. z o.o.
Other research and experimental development on natural sciences and engineering
Overview
Medpolmat develops and implements chemical products, including biodegradable polymers, poly(glycerol sebacate) resins and elastomers, solketal, cosmetic raw materials, synthesis reagents and cleaning wipes. The company adapts polymers for medical applications, develops technologies, carries out pilot-scale and contract manufacturing, and provides analytical and technology consultancy services.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
News
Industry
Bank accounts
Registered as a VAT taxpayer on 2023-02-01. Active
74 1050 1979 1000 0090 8122 1617- 96 1050 1979 1000 0090 8122 1609
- 47 1050 1764 1000 0090 8509 2444
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Trademarks
Medpolmat currently holds no active trademarks with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2025.
| Mark | Protected until | |
|---|---|---|
| procarexpert | – |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a multi-member management board, each member of the management board independently is authorized to sign and submit declarations of will on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Dawid Bińkowski (39) | 17 | $229.61 | 14.4068% |
Mirosław Bińkowski (68) | 17 | $229.61 | 14.4068% |
Agnieszka Anna Gadomska Gajadhur (40) | 36 | $486.22 | 30.5085% |
Tomasz Kryszak (39) | 17 | $229.61 | 14.4068% |
Others | 31 | $418.69 | 26.2711% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Proper Medical Writingsp. z o.o. | $514,848.41 | propermedicalwriting.com | ||
| DigitmedS.A. | $382,907.91 | digitmed.pl | ||
| MedisensonicS.A. | $362,572.63 | medisensonic.com | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| MultiqureS.A. | $284,781.52 | purebiologics.com | ||
| FcbiotechS.A. | $246,877.92 | fcbiotech.pl | ||
| Chemlabsp. z o.o. | $144,354.49 | chemlab.com.pl | ||
| PellicarnosS.A. | $135,043.43 | pellicarnos.com | ||
| AM Lab Solutionssp. z o.o. | $100,896.70 | amsolutions.pl | ||
| Wood Plastic Wastesp. z o.o. | $86,157.40 | woodplasticwaste.pl |
Change history
| Date | Event | |
|---|---|---|
| 2023-09-21 | PKD change (Removed: 20.60.Z, 21.10.Z, 21.20.Z, 22.22.Z, 32.50.Z, 72.11.Z; Added: 20.14.Z, 20.42.Z, 46.45.Z, 46.75.Z, 47.91.Z, 71.12.Z) | |
| 2022-10-31 | Share capital change (5,150.00 PLN → 5,900.00 PLN) | |
| 2022-08-30 | Address change (Ul. Koszykowa 75, 00-662, Warszawa → Ul. Ignacego Mościckiego 1, 24-110, Puławy) | |
| 2021-04-09 | Entered in the register |
FAQ
Last updated: 2026-08-24